Frontlight ResearchEarly access
CompletedPhase 2
An Evaluation of the Long-term Efficacy and Safety of Methylone for the Treatment of PTSD
Key facts
- Who runs it
- Transcend Therapeutics
- Where
- Denver, Draper, and Rockville, United StatesSee the 3 sitesAlso in 2 other countries, 6 sites
- Trial code
- Status
- Completed
- Phase
- Phase 2
- People taking part
- 44 people enrolled
- Started
- 6 Mar 2024
- Ended
- 6 Oct 2025
- Type of study
- Interventional
- Treatments tested
- Methylone
- Record updated
- 16 November 2026
Who can take part
- Age
- 18 years to 71 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 5 criteriaShow less
Who can take part
- Participation in and successful completion of a prior Transcend-sponsored clinical trial with TSND-201
- Agree to not participate in any other interventional clinical trials for the duration of this study
- Willing and able to provide informed consent
Who cannot take part
- Had significant deviation(s)/non-compliance in parent study in the opinion of the Investigator which would deem them unsuitable for participation
- Change or development of any physical or psychological finding that would make participant unsuitable for study
Where in United States
Also in 2 other countries, 6 sites
- Mountain View Clinical ResearchDenver, United States
- Cedar Clinical Research Inc.Draper, United States
- Sunstone MedicalRockville, United States
About the trial
What the trial wants to find out
This is an extension study of participants who previously completed a Transcend-sponsored clinical trial evaluating TSND-201 as a treatment for PTSD.
Read full original descriptionShow less
Participants will be followed for up to 52 weeks. During the 52 week period, PTSD symptoms and safety will be assessed monthly.
Participants' PTSD symptoms will be assessed at each observational visit and if criteria for Relapse has been met, participants may be eligible to receive a course of TSND-201 treatment.
The group in the trial
- Treatment (Methylone)Treatment being tested
Treatment: Methylone
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- A 52-Week, Open-Label Evaluation of the Long-term Efficacy and Safety of Single and Repeated Treatments With Methylone for the Treatment of PTSD IMPACT-EXT (Investigation of Methylone for Post-Traumatic Stress Disorder [PTSD])
- Record updated
- 16 November 2026